Difference between revisions of "Pharm Meeting Minutes 2021.03.17"

From IHE Wiki
Jump to navigation Jump to search
 
(24 intermediate revisions by 2 users not shown)
Line 10: Line 10:
  
 
== Q1  13:00- 14:30 Change proposals & Medication Lists ==
 
== Q1  13:00- 14:30 Change proposals & Medication Lists ==
 +
 +
* Participants:
 +
** Leonidas Tzimis
 +
** Stephane Spahni
 +
** Jose Costa Teixeira
 +
** Michael Tan
 +
** Jurgen Brandstatter
 +
** Jacqueline Surugue
 +
  
 
===Change Proposals ===
 
===Change Proposals ===
 +
 +
* Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.
  
 
Overview: [https://drive.google.com/file/d/1d4TiC2h7qRiS7oEZVDNU2soQULycZyhQ/view?usp=sharing CP Overview]
 
Overview: [https://drive.google.com/file/d/1d4TiC2h7qRiS7oEZVDNU2soQULycZyhQ/view?usp=sharing CP Overview]
  
 
:* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles
 
:* [https://drive.google.com/file/d/1-48FLRY3BEnJuZ_nyz0Bfq1kFiOgWPYI/view?usp=sharing CP-PHARM-142] Proofreading / clarifications on CMPD, MTP, PADV profiles
 +
:** Fixes something we have forgotten when we introduced COMMENT.
 +
:** there are 2 definitions on XDS DocumentEntryType as a parameter.
 +
 
:* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile)
 
:* [https://drive.google.com/file/d/1WdPatA8OYpkD3uk0g1OeBHOrR-lfqBho/view?usp=sharing CP-PHARM-143] Align definitions of doseQuantity & rateQuantity (PRE profile)
 +
:** Dose and rate quantity is herited from PCC. Is it a quantity or a range.  Which unit is allowed.There is a difference with PCC definition.
 
:* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
 
:* [https://drive.google.com/file/d/1hzA_L9iXVIy3sMWqzWHsJdSgMphGLy7G/view?usp=sharing CP-PHARM-144] Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
 +
:** Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction
 
:* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile)
 
:* [https://drive.google.com/file/d/1Yc4_QX9MaSEvYhNHE6gS5Hc3mJFUeOTE/view?usp=sharing CP-PHARM-145] Cross-community PHARM-1 (CMPD profile)
 +
:** A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known.
 
:* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile)
 
:* [https://drive.google.com/file/d/1kko76AnrwaramEwPsHovwj6veCNgT6td/view?usp=sharing CP-PHARM-146] New MHD-based transaction PHARM-5 (CMPD profile)
 +
:** Need to support also RESTbased concepts  which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile.
 +
:** 3 possible solutions.
 +
 
:* [https://drive.google.com/file/d/1ejY288pLJOJVhVZkQmmvPklkDYGvxwgi/view?usp=sharing CP-PHARM-147] moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
 
:* [https://drive.google.com/file/d/1ejY288pLJOJVhVZkQmmvPklkDYGvxwgi/view?usp=sharing CP-PHARM-147] moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
 +
:** In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent.
 
:* [https://drive.google.com/file/d/1m41hAFgwzLys6nmlibP-vg9IrbUJ5Ioi/view?usp=sharing OID Tree]
 
:* [https://drive.google.com/file/d/1m41hAFgwzLys6nmlibP-vg9IrbUJ5Ioi/view?usp=sharing OID Tree]
−
 
+
:** Decide to leave the errors unchanged. Too much risk because of referenced chapters.
 
For information only:
 
For information only:
 
:* [https://drive.google.com/file/d/1QwnGshWO9LYXLAZ9BY2-unaLBMbbZ4sL/view?usp=sharing CP-ITI-xxx] "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
 
:* [https://drive.google.com/file/d/1QwnGshWO9LYXLAZ9BY2-unaLBMbbZ4sL/view?usp=sharing CP-ITI-xxx] "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
Line 28: Line 49:
  
 
=== Medication lists ===
 
=== Medication lists ===
 +
 +
* In Belgium there is understanding that there are different needs for a medication list.
 +
* We cannot force one formula for a medication list.
 +
* The patient records accumulates all the information from different resources.
 +
* Medication as a grouping item.  It is more like a drill down mechanism.
  
 
== 14:30- 15:00 Break ==
 
== 14:30- 15:00 Break ==
Line 34: Line 60:
  
 
=== Participants ===
 
=== Participants ===
 +
 +
* Michael Tan
 +
* Jose Costa Teixeira
 +
* Jurgen Brandstaetter
 +
* Leonidas Tzimis
 +
* Jacqueline Surugue
 +
* Marc Robberecht
 +
* Stéphane Spahni
  
 
== Work items ==
 
== Work items ==
  
−
* Review Doc from Chriss Carr
+
* Review Doc from Chriss Carr [https://docs.google.com/document/d/1kb4U4Yr7m4rJ34vOnezqs5nRKGYyBzPVnrNl-KECQtI/edit?ts=6050cc04 work item]
−
 
 
−
[https://docs.google.com/document/d/1kb4U4Yr7m4rJ34vOnezqs5nRKGYyBzPVnrNl-KECQtI/edit?ts=6050cc04 work item]
 
  
 
== Logical Model ==
 
== Logical Model ==
Line 59: Line 91:
  
 
https://github.com/gcangioli/vaccineCertificate
 
https://github.com/gcangioli/vaccineCertificate
 +
* The Swiss model:
 +
 +
http://fhir.ch/ig/ch-vacd/index.html
 +
 +
 +
Issue to be discussed:
 +
* Site or route to be administered. Do we need to add site?
 +
* Protocol and where to store number of vaccinations. Protocol in the IHE model is a reference. The standard resources is not.
 +
* How to register that a patient only needs one injection.
 +
* What value list do we use for status reason?
 +
 +
* Action:
 +
** Jose to contact Giorgio for the WHO model
 +
** Michael Contact Line Saele and Sylvia Thun
 +
** Stephane to contact HL7 Roeland Luyckx
 +
** Jose to contact HL7 PHER for Gemini
 +
 +
== Any other business ==
  
 +
* Schedule for IHE activities is not clear. Should use the Calendar.
  
 
[[Pharmacy Technical Committee]]
 
[[Pharmacy Technical Committee]]
  
 
[[Category: Minutes]]
 
[[Category: Minutes]]

Latest revision as of 10:44, 17 March 2021

Meeting details

Location

Session 1 Login for Teams
Session 2 Login for Teams

Minutes

Q1 13:00- 14:30 Change proposals & Medication Lists

  • Participants:
    • Leonidas Tzimis
    • Stephane Spahni
    • Jose Costa Teixeira
    • Michael Tan
    • Jurgen Brandstatter
    • Jacqueline Surugue


Change Proposals

  • Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.

Overview: CP Overview

  • CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
    • Fixes something we have forgotten when we introduced COMMENT.
    • there are 2 definitions on XDS DocumentEntryType as a parameter.
  • CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
    • Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition.
  • CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
    • Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction
  • CP-PHARM-145 Cross-community PHARM-1 (CMPD profile)
    • A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known.
  • CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile)
    • Need to support also RESTbased concepts which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile.
    • 3 possible solutions.
  • CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
    • In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent.
  • OID Tree
    • Decide to leave the errors unchanged. Too much risk because of referenced chapters.

For information only:

  • CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
  • CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles

Medication lists

  • In Belgium there is understanding that there are different needs for a medication list.
  • We cannot force one formula for a medication list.
  • The patient records accumulates all the information from different resources.
  • Medication as a grouping item. It is more like a drill down mechanism.

14:30- 15:00 Break

Q2 15:00- 16:30 Vaccination Topics

Participants

  • Michael Tan
  • Jose Costa Teixeira
  • Jurgen Brandstaetter
  • Leonidas Tzimis
  • Jacqueline Surugue
  • Marc Robberecht
  • Stéphane Spahni

Work items

Logical Model

  • WHO model
  • European Model
  • Belgian Model
  • German Model
  • The IHE Pharmacy material can be found here:

https://github.com/IHE/pharm-vaccination

and

http://build.fhir.org/ig/IHE/pharm-vaccination/branches/master/StructureDefinition-ihe-pharm-vaccination.html

  • the WHO FHIR material can be found in Github.

https://github.com/who-int/svc

https://github.com/gcangioli/vaccineCertificate

  • The Swiss model:

http://fhir.ch/ig/ch-vacd/index.html


Issue to be discussed:

  • Site or route to be administered. Do we need to add site?
  • Protocol and where to store number of vaccinations. Protocol in the IHE model is a reference. The standard resources is not.
  • How to register that a patient only needs one injection.
  • What value list do we use for status reason?
  • Action:
    • Jose to contact Giorgio for the WHO model
    • Michael Contact Line Saele and Sylvia Thun
    • Stephane to contact HL7 Roeland Luyckx
    • Jose to contact HL7 PHER for Gemini

Any other business

  • Schedule for IHE activities is not clear. Should use the Calendar.

Pharmacy Technical Committee

Retrieved from "http://wiki.ihe.net/index.php?title=Pharm_Meeting_Minutes_2021.03.17&oldid=124543"